← Back to all trials
Not Yet Recruiting
NCT07693153
The Effects of Psilocybin on Social Connectedness
Conditions: Loneliness, Grief
Sex: All
Ages: 21 Years – 65 Years
Healthy volunteers: Yes
Phase: PHASE1
Enrollment: 51
Sponsor: Yale University
Location: Connecticut Mental Health Center New Haven Connecticut
Summary
The study is a randomized, double-blind, placebo-controlled, expectancy-controlled, mechanistic trial. This study looks to explore whether a single dose of psilocybin (25mg) reduces amygdala reactivity to negative socioemotional stimuli during the Facial Emotion Recognition Task (FERT) compared to a placebo in adults who feel lonely or those with unresolved grief symptoms.
Eligibility Criteria
Inclusion Criteria:
* Medically healthy
* Ability to provide consent
* High loneliness defined by the UCLA-3 Loneliness Scale
* Willingness to comply with all study procedures and availability for the duration of the study
Exclusion Criteria:
* Any unstable medical condition, psychiatric disorder, or circumstance that, in the opinion of the investigator, could compromise participant safety, interfere with study participation, or hinder the participant's ability to comply with study procedures and requirements
* Positive pregnancy test or women who are breastfeeding
* Any contraindication to MRI such as a pacemaker or metal implants
Source: ClinicalTrials.gov (NCT07693153). StuddyBuddy aggregates publicly available trial information.